The Changing Panorama in Risk Factors of Cerebral Palsy

January 15, 2021 updated by: Bilinç Doğruöz Karatekin, Istanbul Medeniyet University

The Changing Panorama in Risk Factors of Cerebral Palsy: A Single National Tertiary Center Experience

The study will be carried of scanning the database of 296 individuals with cerebral palsy followed in the university pediatric rehabilitation clinic. Cerebral palsy risk factors and demographic information will be obtained from the database. The data will be classified according to date of birth, divided into 3 groups: those born before 2000, those born between 2000-2010, and those born after 2010.Changes in cerebral palsy risk factors will be investigated at 10-year intervals.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The study will be carried of scanning the database of 296 individuals with cerebral palsy followed in the university pediatric rehabilitation clinic. Cerebral palsy risk factors and demographic information will be obtained from the database.

Cerebral palsy subtypes classified according to The Surveillance for Cerebral Palsy in Europe (SCPE) classification into four groups: spastic (unilateral and bilateral), dyskinetic (dystonic and choreoathetoic), ataxic/hypotonic, non-classifiable. Cerebral palsy risk factors will be primarily divided into 4 as preconceptional, antenatal, intrapartum and neonatal risk factors. Then, risk factors in the data will be distributed to the appropriate risk factor group.

The data will be classified according to date of birth, divided into 3 groups: those born before 2000, those born between 2000-2010, and those born after 2010. Changes in cerebral palsy risk factors will be investigated at 10-year intervals.

Study Type

Observational

Enrollment (Anticipated)

296

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Istanbul, Turkey, 34732
        • Recruiting
        • Istanbul Medeniyet University Faculty of Medicine, Physical Medicine and Rehabilitation Department
        • Sub-Investigator:
          • Afitap Icagasioglu, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients in our cerebral palsy database

Description

Inclusion Criteria:

  • cerebral palsy patients

Exclusion Criteria:

  • missing data on the cerebral palsy database

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
born before 2000
No patient treatment is associated with the study.
Other: No intervention is associated with the study.
No intervention is associated with the study.
born between 2000-2010
No patient treatment is associated with the study.
Other: No intervention is associated with the study.
No intervention is associated with the study.
born after 2010
No patient treatment is associated with the study.
Other: No intervention is associated with the study.
No intervention is associated with the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Define the risk factors of cerebral palsy
Time Frame: 1 month
Risk factors of cerebral palsy questioned as preconceptional, antenatal, intrapartum and neonatal.
1 month
Define the change in the risk factors among age groups
Time Frame: 1 month
The difference in cerebral palsy risk factors in age groups measured by chi-square statistics (born before 2000/ born between 2000-2010/ born after 2010)
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul Medeniyet University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2021

Primary Completion (Anticipated)

January 30, 2021

Study Completion (Anticipated)

February 20, 2021

Study Registration Dates

First Submitted

January 13, 2021

First Submitted That Met QC Criteria

January 15, 2021

First Posted (Actual)

January 20, 2021

Study Record Updates

Last Update Posted (Actual)

January 20, 2021

Last Update Submitted That Met QC Criteria

January 15, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Istanbul MU CP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe